Disclosures for "Impact of Surface Modification in Flow Diverters for the Embolization of Intracranial Aneurysms: A Comparative Analysis"
-
Author has nothing to disclose
-
Miss Correia Maciel has nothing to disclose.
-
Mr. Lima has nothing to disclose.
-
Dr. Maximiano has nothing to disclose.
-
Dr. Tran has nothing to disclose.
-
Ms. Koppanatham has nothing to disclose.
-
Pichatorn Suppakitjanusant, MD has nothing to disclose.
-
Adam Dmytriw has nothing to disclose.
-
Dr. Nahhas has nothing to disclose.
-
Dr. Sheth has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Penumbra. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerenovus. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imperative Care.
-
Dr. Regenhardt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genomadix. Dr. Regenhardt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rapid Medical. Dr. Regenhardt has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Johnson and Bell Trial Lawyers. Dr. Regenhardt has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Buckley, Theroux, Kline, & Cooley Trial Lawyers. The institution of Dr. Regenhardt has received research support from National Institutes of Health. The institution of Dr. Regenhardt has received research support from Society of Vascular and Interventional Neurology. The institution of Dr. Regenhardt has received research support from Heitman Foundation.